[go: up one dir, main page]

AU2001296084A1 - Paroxetine compositions and processes for making the same - Google Patents

Paroxetine compositions and processes for making the same

Info

Publication number
AU2001296084A1
AU2001296084A1 AU2001296084A AU9608401A AU2001296084A1 AU 2001296084 A1 AU2001296084 A1 AU 2001296084A1 AU 2001296084 A AU2001296084 A AU 2001296084A AU 9608401 A AU9608401 A AU 9608401A AU 2001296084 A1 AU2001296084 A1 AU 2001296084A1
Authority
AU
Australia
Prior art keywords
paroxetine
granulate
sulfonate
composition
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296084A
Other languages
English (en)
Inventor
Jacobus Maria Lemmens
Theodorus Hendricus Antonius Peters
Frantisek Picha
Johannes Jan Platteeuw
Frans Van Dalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Publication of AU2001296084A1 publication Critical patent/AU2001296084A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2001296084A 2000-08-28 2001-08-28 Paroxetine compositions and processes for making the same Abandoned AU2001296084A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22811000P 2000-08-28 2000-08-28
US60228110 2000-08-28
US23493600P 2000-09-26 2000-09-26
US60234936 2000-09-26
PCT/NL2001/000635 WO2002017921A2 (fr) 2000-08-28 2001-08-28 Compositions a base de paroxetine et leurs procedes de fabrication

Publications (1)

Publication Number Publication Date
AU2001296084A1 true AU2001296084A1 (en) 2002-03-13

Family

ID=26922063

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296084A Abandoned AU2001296084A1 (en) 2000-08-28 2001-08-28 Paroxetine compositions and processes for making the same

Country Status (10)

Country Link
US (2) US6645523B2 (fr)
EP (1) EP1313474A2 (fr)
JP (1) JP2004507504A (fr)
AU (1) AU2001296084A1 (fr)
CA (1) CA2418038A1 (fr)
HU (1) HUP0303827A2 (fr)
IL (1) IL154422A0 (fr)
NO (1) NO20030848D0 (fr)
NZ (1) NZ523902A (fr)
WO (1) WO2002017921A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
CA2456233A1 (fr) * 2001-08-02 2003-03-13 Spurcourt Limited Sel d'isethionate de paroxetine, procede de preparation et utilisation dans le traitement de la depression
AU2002330771A1 (en) * 2001-10-22 2003-06-10 Synthon B.V. N-formyl derivatives of paroxetine
WO2003055467A1 (fr) * 2001-12-18 2003-07-10 Synthon B.V. Formes posologiques de simvastatine
WO2003057150A2 (fr) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. Formulation pharmaceutique d'hydrochlorure stable et procédé de préparation
AU2003271055B2 (en) 2002-09-19 2009-03-12 Sumitomo Chemical Company, Limited Methods of crystal precipitation
CA2415154C (fr) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Preparations a liberation modifiee contenant des inhibiteurs selectifs de la recapture de la serotonine
AU2003300694A1 (en) * 2003-04-17 2004-11-04 Ipca Laboratories Limited Pharmaceutical preparations on the basis of moisture-protected granules and a process for producing them
WO2005021056A1 (fr) * 2003-08-21 2005-03-10 Cns, Inc. Systeme de distribution de materiau effervescent
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
WO2007020079A2 (fr) * 2005-08-17 2007-02-22 Synthon B.V. Comprimes de simvastatine a desintegration orale
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CA2673487A1 (fr) * 2006-10-13 2008-04-24 Janssen Pharmaceutica Nv Compositions de phenylalkylaminocarbamate
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
CN109512793B (zh) * 2018-12-25 2021-06-11 哈尔滨珍宝制药有限公司 一种盐酸帕罗西汀制剂及其制备方法以及盐酸帕罗西汀组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
JP2700141B2 (ja) * 1993-09-17 1998-01-19 富士化学工業株式会社 リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
CA2258965A1 (fr) * 1996-06-28 1998-01-08 Oxigene, Inc. Formules utiles de medicaments comportant des sels d'addition d'acides
IL130856A (en) * 1997-01-15 2001-09-13 Smithkline Beecham Plc Proxtin preparations in spray-dry condition and their preparation
ES2155995T3 (es) * 1997-06-10 2001-06-01 Synthon Bv Compuestos de 4-fenilpiperidina.
GB9812941D0 (en) * 1998-06-16 1998-08-12 Smithkline Beecham Plc Method of treatment
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina

Also Published As

Publication number Publication date
WO2002017921A2 (fr) 2002-03-07
US20040067254A1 (en) 2004-04-08
JP2004507504A (ja) 2004-03-11
US6645523B2 (en) 2003-11-11
EP1313474A2 (fr) 2003-05-28
WO2002017921A3 (fr) 2002-10-03
NZ523902A (en) 2004-05-28
CA2418038A1 (fr) 2002-03-07
NO20030848L (no) 2003-02-24
HUP0303827A2 (hu) 2004-04-28
NO20030848D0 (no) 2003-02-24
US20020065301A1 (en) 2002-05-30
IL154422A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
US6645523B2 (en) Paroxetine compositions and processes for making the same
EP1049467B1 (fr) Compositions a base de celecoxib
EP2393485B1 (fr) Comprimé bicouche contenant de l'elvitegravir, du cobicistat, de l'emtricitabine et du tenofovir
JP2002509886A (ja) メロキシカムの経口投与用新規ガレヌス調製物
CZ298675B6 (cs) Farmaceutický prostredek obsahující klodronát a mikrokrystalickou celulózu s oxidem kremicitým
EP2242483B1 (fr) Composition de raloxifène
OA12707A (en) Intraorally disintegrating valdecoxib compositions.
AU7950200A (en) Method for stabilizing benzimidazole compounds
CA2412464A1 (fr) Tannate de dextromethorphane
CN116869915A (zh) 含有苯并咪唑衍生物的新型制剂
WO2007134845A2 (fr) Composition pharmaceutique d'olanzapine
EP2101742B1 (fr) Composition pharmaceutique contenant de l'hydrogénosulfate de clopidogrel de forme polymorphe 1
EP1976522A1 (fr) Préparation pharmaceutique contenant du montélukast
CA2535529A1 (fr) Sels de phenylephrine tannate, pyrilamine tannate, et dextromethorphan tannate utilises dans des compositions pharmaceutiques
TWI651085B (zh) Ｎ－［５－［２－（３，５－二甲氧基苯基）乙基］－２ｈ－吡唑－３－基］－４－［（３ｒ，５ｓ）－３，５－二甲基哌－１－基］苯甲醯胺之醫藥調配物
KR101817714B1 (ko) 발사르탄을 포함하는 경구용 고형 제제
JP2004010575A (ja) 溶解性を改善した医薬組成物
WO2025195451A1 (fr) Compositions pharmaceutiques, formes posologiques et leurs procédés de préparation et d'utilisation
EP1803457A1 (fr) Composition pharmaceutique contenant du montelukast
KR20250118711A (ko) 티로신 키나제 저해제를 유효성분으로 하는 생체이용률이 개선된 경구투여용 제제
TR2022013345A2 (tr) Si̇nnari̇zi̇n ve di̇menhi̇dri̇nat kombi̇nasyonu i̇çeren farmasöti̇k kompozi̇syon
WO2002011726A1 (fr) Preparation solide hautement absorbable
JP2003104891A (ja) 塩酸シプロフロキサシンの医薬組成物
KR20230009327A (ko) 제제 안정성이 향상된 테노포비르 알라펜아미드 함유 속방성 제제
TW202227047A (zh) 甲狀腺荷爾蒙的製劑化方法